Smith & Nephew plc (SNN)

GB — Healthcare Sector

Peers: CHEOY ITGR CFMS MOTS OFIX NUVA GKOS HSKA BRKR GMED CNMD ATEC LIVN IRTC KIDS FNA

Automate Your Wheel Strategy on SNN

With Tiblio's Option Bot, you can configure your own wheel strategy including SNN - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

symbol SNN
Rev/Share 6.6514
Book/Share 6.0274
PB 2.3916
Debt/Equity 0.6308
CurrentRatio 2.8877
ROIC 0.0612

MktCap 12613773675.0
FreeCF/Share 0.6938
PFCF 20.8148
PE 30.562
Debt/Assets 0.3207
DivYield 0.026
ROE 0.0787

Rating B+
Score 3
Recommendation Neutral
P/E Score 2
DCF Score 4
P/B Score 3
D/E Score 1

Recent Analyst Ratings

Type	Ticker	Analyst Firm	Previous Rating	Current Rating	Previous Price Target	Current Price Target	Date
Downgrade	SNN	HSBC Securities	Buy	Hold	--	--	April 25, 2025
Downgrade	SNN	UBS	Buy	Neutral	--	--	March 12, 2025

News

Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer

SNN
Published: June 23, 2025 by: GlobeNewsWire
Sentiment: Neutral

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the appointment of Ajay Dhankhar, PhD, as Chief Corporate Development & Strategy Officer, effective today. Ajay will report to Chief Executive Officer Deepak Nath and join the Smith+Nephew Executive Committee.

image for news Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer

Smith+Nephew Stock May Gain From Strategic Deal With Standard Health

SNN
Published: June 20, 2025 by: Zacks Investment Research
Sentiment: Positive

SNN teams with Standard Health to launch the United Kingdom's first orthopedic ASC, aiming to boost surgical efficiency and drive growth.

image for news Smith+Nephew Stock May Gain From Strategic Deal With Standard Health

New medial stabilized insert for Smith+Nephew's LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility

SNN
Published: June 09, 2025 by: GlobeNewsWire
Sentiment: Neutral

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of a new medial stabilized insert for its LEGION Total Knee System (TKS). Medial stabilized inserts are seeing a steep rise in popularity, growing from 4% of Total Knee Arthroplasty procedures in 2018 to 32% in 2023.1

image for news New medial stabilized insert for Smith+Nephew's LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility

Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense

SNN
Published: May 27, 2025 by: GlobeNewsWire
Sentiment: Neutral

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has been selected to provide its RENASYS◊ TOUCH Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year* contract for up to $75 million by the U.S. Department of Defense (DoD) through the Defense Logistics Agency (DLA).

image for news Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense

Smith & Nephew shares jump 7% on better-than-expected quarterly growth

SNN
Published: April 30, 2025 by: Proactive Investors
Sentiment: Positive

Smith & Nephew PLC (LSE:SN) rose as much as 7% in afternoon trading on Wednesday after the medical technology group reported stronger-than-expected revenue growth in the first quarter of 2025. The London-listed company posted underlying revenue growth of 3.1% in the three months to March, ahead market consensus of 1.9%.

image for news Smith & Nephew shares jump 7% on better-than-expected quarterly growth

Smith & Nephew jumps as hip and knee replacements in demand

SNN
Published: April 30, 2025 by: Proactive Investors
Sentiment: Positive

Smith & Nephew PLC (LSE:SN) shares rose over 5% to top the early FTSE 100 leaderboard on Wednesday after the knee and hip replacer maintained its full-year 2025 guidance after seeing growth of 3.1% in underlying revenue for the first quarter. The performance was supported by recent product launches and continued operational improvements across its business lines, with total reported revenue up 1.6% to $1.4 billion after a negative foreign exchange, ongoing headwinds from China and one fewer trading day compared to the prior year.

image for news Smith & Nephew jumps as hip and knee replacements in demand

New Strong Buy Stocks for April 29th

ALEX, LTH, MATX, PCB, SNN
Published: April 29, 2025 by: Zacks Investment Research
Sentiment: Positive

MATX, SNN, ALEX, PCB and LTH have been added to the Zacks Rank #1 (Strong Buy) List on April 29, 2025.

image for news New Strong Buy Stocks for April 29th

Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025

SNN
Published: March 11, 2025 by: GlobeNewsWire
Sentiment: Neutral

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will feature the latest advancements in Orthopaedic Reconstruction at the American Academy of Orthopaedic Surgeons Annual Meeting in San Diego this week. Some of the highlighted technologies will include:

image for news Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025

Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025

SNN
Published: March 10, 2025 by: GlobeNewsWire
Sentiment: Neutral

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will showcase the latest advancements in Sports Medicine for joint repair at the American Academy of Orthopaedic Surgeons Annual Meeting in San Diego this week. Some of the highlighted technologies will include:

image for news Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025

New report confirms Smith+Nephew's OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty

SNN
Published: March 06, 2025 by: GlobeNewsWire
Sentiment: Neutral

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce that the latest annual report from the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) highlights the exceptional performance of Smith+Nephew's proprietary OXINIUM on highly cross-linked polyethylene. The data indicates that this combination has the highest survivorship rate (94.1%) among all bearing combinations over a 20-year period for total hip arthroplasty (THA).1

image for news New report confirms Smith+Nephew's OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty

Smith & Nephew sees turnaround plan kicking in as profit grows

SNN
Published: February 25, 2025 by: Proactive Investors
Sentiment: Positive

Smith & Nephew PLC has said 2025 should show its transformation plan kicking in despite ongoing woes in China after improving trading over the last year. Revenue climbed 4.7% to US$5.8 billion in the year to December 31, the medical equipment maker said Tuesday, aiding an 8.2% increase in trading profit to US$1.1 billion.

image for news Smith & Nephew sees turnaround plan kicking in as profit grows

UK's Smith+Nephew beats annual profit expectations

SNN
Published: February 25, 2025 by: Reuters
Sentiment: Positive

Smith+Nephew beat analysts' expectations for annual sales and profit on Tuesday, as a recovery in its U.S. knee and hip implant business, along with cost cuts, helped the medical products maker offset the impact of weak demand from China.

image for news UK's Smith+Nephew beats annual profit expectations

Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand

SNN
Published: February 16, 2025 by: GlobeNewsWire
Sentiment: Neutral

First in market to o ffe r A djustable T ensioning T echnology * for i nsertional A chilles r econstruction and l ateral a nkle i nstability r epair

image for news Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand

About Smith & Nephew plc (SNN)

IPO Date 1999-11-16
Website https://www.smith-nephew.com
Industry Medical - Devices
CEO Dr. Deepak S. Nath Ph.D.
Employees 17349

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.